Kwality Pharmaceuticals Limited (BOM:539997)
3,590.75
+146.00 (4.24%)
At close: Aug 17, 2026
Kwality Pharmaceuticals Earnings Call Transcripts
Fiscal Year 2027
-
Revenue guidance for FY 2027 is raised to over INR 700 crore with EBITDA margins of 26%-27%, driven by new product registrations and expansion in LATAM and MENA regions. Major CapEx is planned for hormone, oncology, and biosimilar programs, with strong growth expected through FY 2030.